Compare Cigna Corp (CI) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Visa Inc — how do they compare? Cigna Corp trades at $303.58 (market cap $80.25B), while Visa Inc trades at $358.83 (market cap $677.06B). The key difference: Visa Inc is far larger — about 8.4× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| CI | V | |
|---|---|---|
Market Cap | $80.25B | $677.06B |
Sector | Health | Financials |
52-Week High | $311.00 | $362.13 |
52-Week Low | $244.41 | $295.52 |
Enterprise Value | $103.35B | $687.65B |
Dividend Yield | 2.06% | 0.75% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
Visa (V) trades at $357.01, down 0.21% on the day, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding the $3.10 estimate. Revenue grew to $40 billion in 2025, and net income margin remains robust at 51.68%. Recent news highlights Visa's expansion into AI-driven commerce and stablecoin partnerships, positioning it for future growth in digital payments.
Outlook remains positive with an 85% analyst buy rating and a consensus price target of $394.50, implying 10.5% upside. Key risks include competitive threats from fintech and regulatory pressures. The stock's valuation multiples are elevated, but consistent profitability and strategic initiatives support long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
